11 October 2016 – The Strategic advisory group on malaria eradication, established to address issues on the feasibility, expected costs, timelines and potential strategies for achieving eradication, held its first meeting on 29–30 August.
29 September 2016 – The new "Plan of Action for Malaria Elimination 2016–2020", aligned with WHO’s "Global Technical Strategy for Malaria 2016–2030", seeks to intensify elimination efforts in all 21 endemic countries of the region.
22 July 2016 – Global progress in malaria control is threatened by the rapid development and spread of antimalarial drug resistance. To date, parasite resistance to artemisinin – the core compound of the best available antimalarial medicines – has been detected in 5 countries of the Greater Mekong subregion.
14 July 2016 – The next meeting of the Malaria Policy Advocacy Committee (MPAC) will take place in Geneva, Switzerland on 14–16 September. All related documentation will be made available on the MPAC meetings page.
23 June 2016 – This updated glossary aims to improve communication and mutual understanding within the scientific community as well as with funding agencies and other malaria stakeholders. It will be available in French and Spanish shortly.
31 May 2016 – WHO and FAO held a Joint Meeting on Pesticide Residues (JMPR) to re-evaluate the safety of three pesticides, including malathion, an insecticide used in vector control for malaria and other vector-borne diseases.
31 May 2016 – WHO has published an update on the status of artemisinin resistance in affected countries. The update summarizes WHO's current policy and treatment recommendations and highlights areas of concern.
5 May 2016 – WHO has developed a set of standard operating procedures (SOPs) to guide microscopists working at all levels of the health care system on the correct procedures for performing microscopy diagnosis for malaria.
25 April 2016 – World Malaria Day 2016: End malaria for good This year’s theme, "End malaria for good", reflects the vision of a malaria-free world set out in the Global Technical Strategy for Malaria 2016-2030.
30 March 2016 – WHO is rigorously reviewing reports of P. falciparum genetic mutations in some African settings to determine their accuracy and supporting countries to investigate suspected false negative rapid diagnostic test (RDT) results consistent with a missing pfhrp2 gene.
5 March 2016 – Dr Pedro Alonso has been awarded the Ronald Ross Medal by the London School of Hygiene and Tropical Medicine. The medal is awarded every 3 years in recognition of outstanding contributions to the advancement of tropical public health or tropical medicine
29 February 2016 – The technical brief covers several key strategic areas aimed at controlling and eliminating P. vivax including diagnostic testing and treatment, G6PD deficiency and radical cure with primaquine, and surveillance.
24 February 2016 – The report on the Septmber 2015 Malaria Policy Advisory Committee meeting is now available. The report and all related documentation can be consulted on the dedicated MPAC meetings page.
23 February 2016 – This module is designed to provide the necessary skills and knowledge to assess the feasibility of malaria elimination in a given area and to prepare a national or sub-national plan for an elimination programme.
12 February 2016 – The next meeting of the Malaria Policy Advocacy Committee (MPAC) will take place in Geneva, Switzerland on 16–17 March. All related documentation can be found on the MPAC meetings page.
3 February 2016 – This manual is designed to assist managers of national malaria programmes and reference laboratories in investing in quality assurance of malaria microscopy. It will be released in French and Spanish soon.
29 January 2016 – RTS,S/AS01 is a vaccine that provides partial protection against P. falciparum, the most deadly malaria parasite globally. The recently updated Q&A on malaria vaccines provides additional information.
15 January 2016 – These recommendations focus on the use of LLINs treated with a pyrethroid insecticide and piperonyl butoxide, and on the need to gather more evidence on conditions and settings where they have increased efficacy compared to pyrethroid-only LLINs.
9 January 2016 – WHO, FIND and US CDC have released the latest report on malaria RDT product testing. The report provides a comparative measure of RDT performance in a standardized way to distinguish between well and poorly performing tests.